Roswell Park Comprehensive Cancer Center

Welcome to Roswell Park Comprehensive Cancer Center. One of the largest employers in Western New York, Roswell Park has over 3,500 employees and is the only National Cancer Institute-designated comprehensive cancer center in New York outside of New York City. Founded in 1898 by Dr. Roswell Park as America's first cancer center, Roswell Park set the standard for cancer centers across the country and world to follow. Equipped with the best facilities and the single objective of curing cancer, we have the sharpest and most creative minds working together in the classroom, laboratory and clinic to accelerate discovery and speed the delivery of promising new cancer treatments. The Institute is recognized by the National Cancer Institute (NCI) as one of only 51 Comprehensive Cancer Centers in the U.S. This designation signifies that all research, treatment and educational programs meet rigorous national standards and that the Institute has contributed fundamentally to the fight against cancer. Roswell Park is also a member of the National Comprehensive Cancer Network (NCCN), an alliance of the nation's leading cancer centers. A not-for-profit organization, the NCCN brings together the best minds in science to engineer continuous quality improvements in cancer care, improves the effectiveness of cancer care delivery through the ongoing collection and analysis of outcome data on a national basis, enhances communications and collaboration among member institutions, offers access to the latest, most promising clinical trials, and provides best practice guidelines and measurement tools. Roswell Park has achieved accreditation from the The Joint Commission (TJC) as a result of its demonstrated compliance with TJC's nationally recognized health care standards. The innovative quality of our faculty’s research has earned Roswell Park a place among the National Cancer Institute’s top grantees. Over the past century, Roswell Park has been the source of historic breakthroughs in the field of oncology. Roswell Park initiated the nation’s first chemotherapy research program. Roswell Park conducted some of the earliest studies linking smoking to lung cancer. Roswell Park developed the PSA test for prostate-cancer screening. Roswell Park developed photodynamic therapy (PDT), approved by the FDA for the treatment of esophageal cancer and non-small cell lung cancer, and precancerous lesions in patients with Barrett's esophagus. Roswell Park is now developing the second generation of PDT drugs. Roswell Park geneticists created the gene library used to map and sequence the human genome. An Roswell Park geneticist was part of the research team involved in the international effort.